Request For Quotation For Possible Award Pursuant To Art. 50, Paragraph 1, Letter B) Of Legislative Decree 31 March 2023 N. 36 And Amendments For The Supply Of The Active Ingredients Bupivacaine Hydrochloride, Sodium Chloride 2 Meq/Ml 10 Ml Iv In Glass, Sodium Calcium Edetate, Carbocisteine Lysine Salt Monohydrate, Butylscopolamine (Scopolamine Butylbromide), Fusidic Acid And Atorvastatin

ASST DI CREMONA Italy has Released a tender for Request For Quotation For Possible Award Pursuant To Art. 50, Paragraph 1, Letter B) Of Legislative Decree 31 March 2023 N. 36 And Amendments For The Supply Of The Active Ingredients Bupivacaine Hydrochloride, Sodium Chloride 2 Meq/Ml 10 Ml Iv In Glass, Sodium Calcium Edetate, Carbocisteine Lysine Salt Monohydrate, Butylscopolamine (Scopolamine Butylbromide), Fusidic Acid And Atorvastatin in Chemicals. The tender was released on Nov 21, 2024.

Country - Italy

Summary - Request For Quotation For Possible Award Pursuant To Art. 50, Paragraph 1, Letter B) Of Legislative Decree 31 March 2023 N. 36 And Amendments For The Supply Of The Active Ingredients Bupivacaine Hydrochloride, Sodium Chloride 2 Meq/Ml 10 Ml Iv In Glass, Sodium Calcium Edetate, Carbocisteine Lysine Salt Monohydrate, Butylscopolamine (Scopolamine Butylbromide), Fusidic Acid And Atorvastatin

Deadline - Dec 03, 2024

GT reference number - 98013762

Product classification - Chemical products